SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001005477-05-003240
Filing Date
2005-09-19
Accepted
2005-09-19 07:29:33
Documents
1
Period of Report
2005-09-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 edgar123.html 3  
1 FORM 3 edgar123.xml 3 3629
  Complete submission text file 0001005477-05-003240.txt   5560
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 579 BELLEVUE AVE NEWPORT RI 02840
Business Address C/O PROTEIN DESIGN LABS 34801 CAMPUS DR FREMONT CA 94555 4018420755
DAWES KAREN A (Reporting) CIK: 0001261506 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-14656 | Film No.: 051090151